Financials

MDxHealth operates on a calendar basis with its accounting year ending on December 31.

The company reports its consolidated financial statements under International Financial Reporting Standards (IFRS) and all amounts are in US Dollars. MDxHealth publishes a consolidated and audited Annual Report on an annual basis, a consolidated Interim Report for its June 30 half-year financial figures, and business/financial updates at the end of Q1 and Q3. Furthermore, for the Annual General Shareholders’ Meeting, the company also publishes the non-consolidated Belgian-GAAP financial statements of the parent company. Prior to October 5, 2010, MDxHealth operated under the name OncoMethylome Sciences.

 

Reporting Calendar

  • Publication FY 2017 results: February 22, 2018
  • Publication of first interim trading update: April  24, 2018
  • Publication  H1 results:  August 30,  2018
  • Publication of second interim trading update: October 23, 2018
  • Annual General Meeting of Shareholders: May 31, 2018

 

 

3-year Snapshot  
Condensed Consolidated Statement of Comprenhsive Income
In '000 of USD 2017 2016 2015
Revenues 40,508 29,970 17,640
Gross Profit 30,305 19,867 10,735
Research and Development Expenses 3,505 1,977 3,257
Selling, General and Adminisitrative Expenses 39,142 30,953 22,358
Other Operating (Income)/Expenses 68 217 498
Other Profit/(Loss)(Ebit) -12,274 -12,846 -14,382
Financial Income 137 36 13
Financial Expenses 10 477 104
Income Taxes -113 -113 -
Net Profit/(Loss -12,288 -13,147 -14,473
       
Consolidated Statement of Financial Position
In '000 of USD      
Assets 2017 2016 2015
Total Non-Current Assets 19,205 16,233 13,096
Total Current Assets 39,646 51,488 44,646
Of Which Cash and Cash Equivalents 16,827 30,871 31,680
Total Assets 58,521 67,721 57,742
       
Liabilities and Shareholders’ Equity      
Total Equity 43,546 52,741 44,262
Non-Current Liabilities 1,860 2,387 2,655
Current Liabilities 13,115 12,593 10,825
       
Consolidated Cash Flow Statement      
In '000 of USD 2017 2016 2015
Operating Cash Flow -10,489 -16,585 -14,394
Investing Cash Flow -6,053 -5,316 -7,576
Financing Cash Flow 573 21,095 35,042
Net Change in Cash and Cash Equivalents -15,969 -806 13,072
Cash and Cash Equivalents at End of Period 16,827 30,871 31,680

Financial Reports

2017

  • 2017 Consolidated figures: english
  • 2017 Interim report: english français
  • 2017 Annual Report "after correction to take into account a clerical drafting error": english français
  • Full year 2017 Non Consolidated Statutory Account: français
  • Auditors Opinion: english français
  • Board Report on 2017 Financial Statements "after correction to take into account a clerical drafting error": english français

2016

2015

2014

2013

2012

2011

2010

2009

2008

2007

2006

  • Full year 2006 Registration Document (Annual Report): english français
  • 2006 Full Year Results: english français
  • 2006 Full Year Results Financial Report: english
  • Statutory Statements with Reports of Board and Auditor: english
  • 2006 Half year Report (June 30 figures): français